Literature DB >> 2541143

Characterization of the membrane-associated GTPase activity: effects of chemotactic factors and toxins.

C Pelz1, T Matsumoto, T F Molski, E L Becker, R I Sha'afi.   

Abstract

Membranes prepared from rabbit neutrophils exhibit GTPase activity which can be stimulated by the chemotactic factor fMet-Leu-Phe. The maximum contribution of the ATPase activities to the basal and the fMet-Leu-Phe-stimulated GTPase activities are less than 20% and 9%, respectively. The basal GTPase activity has a Vmax = 34.2 +/- 1.3 (pmol/mg protein, min) and a Km = 0.39 +/- 0.03 microM; and the fMet-Leu-Phe-stimulated has a Vmax = 52.3 +/- 2.5 (pmol/mg protein, min), and a Km = 0.29 +/- 0.02 microM. The GTPase activity can be stimulated by fMet-Leu-Phe and leukotriene B4. Unlike these two chemotactic factors, concanavalin A does not stimulate this GTPase activity. In addition, the rise in intracellular concentration of free calcium produced by concanavalin A is not inhibited by pertussis toxin treatment. Both the basal and stimulated GTPase activities are affected by pertussis toxin, cholera toxin and N-ethylmaleimide.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2541143     DOI: 10.1002/jcb.240390211

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  10 in total

1.  Effect of interferon-alpha on neutrophil functions.

Authors:  S Kasimir; J Brom; W König
Journal:  Immunology       Date:  1991-10       Impact factor: 7.397

2.  Granulocyte-macrophage colony-stimulating factor and human neutrophils: role of guanine nucleotide regulatory proteins.

Authors:  J Gomez-Cambronero; M Yamazaki; F Metwally; T F Molski; V A Bonak; C K Huang; E L Becker; R I Sha'afi
Journal:  Proc Natl Acad Sci U S A       Date:  1989-05       Impact factor: 11.205

3.  Rescue of glandular dysmorphogenesis in PTEN-deficient colorectal cancer epithelium by PPARγ-targeted therapy.

Authors:  I Jagan; A Fatehullah; R K Deevi; V Bingham; F C Campbell
Journal:  Oncogene       Date:  2012-04-30       Impact factor: 9.867

4.  Leukotriene A4 modulates generation of leukotriene B4 and sulphidopeptide leukotrienes by human neutrophils.

Authors:  R A Hilger; W König
Journal:  Immunology       Date:  1992-11       Impact factor: 7.397

5.  Transforming growth factor beta 1, a potent chemoattractant for human neutrophils, bypasses classic signal-transduction pathways.

Authors:  J Reibman; S Meixler; T C Lee; L I Gold; B N Cronstein; K A Haines; S L Kolasinski; G Weissmann
Journal:  Proc Natl Acad Sci U S A       Date:  1991-08-01       Impact factor: 11.205

6.  Granulocyte-macrophage colony-stimulating factor-induced protein tyrosine phosphorylation of microtubule-associated protein kinase in human neutrophils.

Authors:  J Gomez-Cambronero; C K Huang; T M Gomez-Cambronero; W H Waterman; E L Becker; R I Sha'afi
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-15       Impact factor: 11.205

7.  Transforming growth factor-alpha increases tyrosine phosphorylation of microtubule-associated protein kinase in a small intestinal crypt cell line (IEC-6).

Authors:  B L Oliver; R I Sha'afi; J J Hajjar
Journal:  Biochem J       Date:  1994-10-15       Impact factor: 3.857

8.  Cytoplasmic phospholipase A2 translocates to membrane fraction in human neutrophils activated by stimuli that phosphorylate mitogen-activated protein kinase.

Authors:  M Durstin; S Durstin; T F Molski; E L Becker; R I Sha'afi
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-12       Impact factor: 11.205

9.  Sulphasalazine inhibition of human granulocyte activation by inhibition of second messenger compounds.

Authors:  G Carlin; R Djursäter; G Smedegård
Journal:  Ann Rheum Dis       Date:  1992-11       Impact factor: 19.103

10.  Up-regulation of the amount of Gi alpha 2 associated with the plasma membrane in human neutrophils stimulated by granulocyte-macrophage colony-stimulating factor.

Authors:  M Durstin; S R McColl; J Gomez-Cambronero; P H Naccache; R I Sha'afi
Journal:  Biochem J       Date:  1993-05-15       Impact factor: 3.857

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.